These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7238474)

  • 1. Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans.
    Ratech H; Thorbecke GJ; Meredith G; Hirschhorn R
    Enzyme; 1981; 26(2):74-84. PubMed ID: 7238474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene on human chromosome 6 functions in assembly of tissue-specific adenosine deaminase isozymes.
    Koch G; Shows TB
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3876-80. PubMed ID: 279003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and catalytic properties of the isozymes of adenosine deaminase from human red blood cells.
    MacQuarrie R; Buel E
    Mol Cell Biochem; 1982 Oct; 48(2):121-6. PubMed ID: 7144744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of adenosine deaminase isozymes from normal human erythrocytes.
    Van Heukelom LH; Boom A; Bartstra HA; Staal GE
    Clin Chim Acta; 1976 Oct; 72(1):109-15. PubMed ID: 10102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit.
    Hirschhorn R
    J Clin Invest; 1975 Mar; 55(3):661-7. PubMed ID: 1117071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
    Schrader WP; Pollara B; Meuwissen HJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
    Hunt SW; Hoffee PA
    J Biol Chem; 1982 Dec; 257(23):14239-44. PubMed ID: 6815190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase activity of chicken erythrocyte and heart cytosols.
    Spivey DB; Snow LD
    Int J Biochem; 1989; 21(6):645-8. PubMed ID: 2792550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.
    Conlon BA; Law WR
    Clin Exp Immunol; 2004 Oct; 138(1):14-20. PubMed ID: 15373900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase.
    Caiolfa VR; Gill D; Parola AH
    FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
    Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase.
    Spector T; Jones TE; Beacham LM
    Biochem Pharmacol; 1983 Sep; 32(17):2505-9. PubMed ID: 6351865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
    Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
    Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum adenosine deaminase and its isozyme activity in leukemia and MDS].
    Ohata M; Masuda I; Nonaka K; Sugiura K; Uchida H; Mori T
    Rinsho Byori; 1990 Aug; 38(8):917-22. PubMed ID: 2232254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase isozymes in Artemia.
    Fernández A; Canales J; Pinto RM; Faraldo A; Sillero MA; Sillero A
    Comp Biochem Physiol B; 1984; 78(2):481-4. PubMed ID: 6467911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
    Franco R; Hoyle CH; Centelles JJ; Burnstock G
    Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Sutherland DE; Foker JE; Najarian JS
    Surg Forum; 1977; 28():320-2. PubMed ID: 364724
    [No Abstract]   [Full Text] [Related]  

  • 20. AMP deaminase isozymes in human tissues.
    Ogasawara N; Goto H; Yamada Y; Watanabe T; Asano T
    Biochim Biophys Acta; 1982 Feb; 714(2):298-306. PubMed ID: 7034783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.